Michelle Cooper
Adult Health · Martinsburg, WVNPI 1316119365
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $912 and has fallen 65.0% since, to $319 in 2025.
Across 86 payments — averaging $24.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$299
- Novo Nordisk$254
- AbbVie$237
- Amgen$221
- AstraZeneca$181
- Lilly USA, LLC$138
- plus $756 from 15 others
What the payments were for
- Food & beverage$2,086100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 12 | $299 |
| Novo Nordisk | 17 | $254 |
| AbbVie | 5 | $237 |
| Amgen | 4 | $221 |
| AstraZeneca | 6 | $181 |
| Lilly USA, LLC | 9 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $125 |
| Boston Scientific | 2 | $115 |
| GSK | 2 | $103 |
| Phathom Pharmaceuticals, Inc. | 1 | $97 |
| Pfizer | 3 | $54 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| Biohaven Pharmaceuticals, Inc. | 2 | $33 |
| Evofem Biosciences, Inc. | 2 | $30 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Merck | 1 | $20 |
| Gilead | 1 | $19 |
| Novartis | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $12 |
| Organon | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,086 in reported general payments places this provider in the 85th percentile of 30 adult health providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 15 | $179 |
| Lisinopril | 13 | $138 |
Paid to pharmacies, not to this prescriber.
Other adult health in Martinsburg
- Susan ReynoldsMartinsburg$16
- Jean KernalMorgantown$6K
- Megan GeyerRavenswood$3K
- John ArrudaMorgantown$3K
- Laura MayerHuntington$2K
- Laurie JonesCharleston$1K
- Amy PatrickWheeling$1K
- Bridget BriscoeRavenswood$1K
- Nolan SankoffCharleston$1K
- Michael EdmistonMorgantown$766
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.